Clinical Chemistry

In Other News

• ADLM Issues Laboratory Guidance for Gender-Diverse Patient Care

• FDA-Approved Test Identifies Low Risk of Large Esophageal Varices in Cirrhosis

• Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes

• Blood Test Detects More High-Risk Prostate Cancers Than PSA

• Rapid Blood Test Aids Diagnosis of Acute Ischemic Stroke

• Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

• Blood-Based Alzheimer’s Testing Platform Offers Rapid Results

• New Blood Test Predicts Organ-Specific Disease and Mortality Years in Advance

• Simple Oral Swab Monitors Persistent Inflammation in Primary Ciliary Dyskinesia

• Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

• Plasma Vitamin C Levels Associated with Brain Structure and Connectivity in Aging

• Mass Spectrometry Detects Tumor Metabolites for Cancer Monitoring

• Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures

• Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead

• Bedside CSF Monitor Detects Early Infection in Fluid Drains

• Saliva-Based Test Detects Biochemical Signs of Sleep Loss

• Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease

• Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia

• Urine-Based Test Shows Promise for Autism Screening in Children

• Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

• Blood-Based Sensor Detects Early Signs of Alzheimer’s and Parkinson’s

• Urine-Based Alzheimer’s Test Receives FDA Breakthrough Device Designation

• Fluid Biomarker Improves Diagnosis and Monitoring of Primary CNS Lymphoma